TOKYO, Dec. 24,
2024 /PRNewswire/ -- Kaneka has successfully defended
its patent for stabilizing Ubiquinol. On December 20, 2024, Kaneka Corporation won its
lawsuit against Designs for Health, Inc. and American River Nutrition, LLC for infringement of
Kaneka's U.S. Patent No. 7,829,080 (the "'080 Patent"). The '080
Patent teaches a method of stabilizing ubiquinol against oxidation
with a specific composition of chemical compounds. Ubiquinol is the
reduced form of the health supplement coenzyme Q10, a powerful
antioxidant that promotes cellular energy and heart health, which
is more absorbable by the body than its oxidized form. Kaneka
commenced its patent infringement action against defendants in 2021
in the United States District
Court for the District of Delaware.
Senior Judge William Bryson of
the Federal Circuit, sitting by designation in the District Court,
found that Design For Health, Inc.'s products, CoQNOL and Q10.1,
which contain a formulation of ubiquinol known as DuoQuinol,
infringe Kaneka's '080 Patent. Judge Bryson also rejected
defendants' arguments that the '080 Patent was invalid under
Section 101 for lack of patent-eligible subject matter, Section 102
for anticipation, Section 103 for obviousness, and Section 112 for
lack of written description. Judge Bryson will determine the amount
of Kaneka's monetary damages next year.
"We are pleased that Judge Bryson has vindicated Kaneka's
position that the '080 Patent was both infringed and valid" said
Mr. Kazuhiko Fujii, President of
Kaneka. "This victory is tangible proof of Kaneka's resolve
to fully enforce its patent rights, including its patents covering
ubiquinol. The protection of Kaneka's patent rights is paramount to
Kaneka's business. Kaneka's commitment to protecting these rights
is unwavering."
Case Number: C.A. No. 21-209-WCB
Contact info: Ron Martin, Vice
President, Kaneka North America -
ronald.martin@kaneka.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/designs-for-health-inc-held-liable-for-infringement-of-kanekas-ubiquinol-patent-302338964.html
SOURCE Kaneka Corporation
